Dutch-based Matisse Pharmaceuticals secures €3.6M to help treat sepsis Startups January 4, 2024 [ad_1] Geelan, the Netherlands-based Matisse Prescription drugs, a clinical-stage firm growing a medicinal product for sepsis, introduced on Thursday, that…
